Showing results (2311-2320 of 2,888) with videos related to
Sort By:
Pageof 289
Journal of Cardiac Failure|May 23, 2007
Hypertrophy and heart failure in mice overexpressing the cardiac sodium-calcium exchangerKenneth P Roos, Maria C Jordan, Michael C Fishbein, et al.JAMA|June 3, 2010
Trends in length of stay and short-term outcomes among Medicare patients hospitalized for heart failure, 1993-2006Héctor Bueno, Joseph S Ross, Yun Wang, et al.The Oncologist|June 3, 2021
Comparative Genomic Analysis of Intrahepatic Cholangiocarcinoma: Biopsy Type, Ancestry, and Testing PatternsMason A Israel, Natalie Danziger, Kimberly A McGregor, et al.Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|March 4, 2020
Melanomas with activating RAF1 fusions: clinical, histopathologic, and molecular profilesErik A Williams, Nikunj Shah, Meagan Montesion, et al.European Heart Journal|May 11, 2023
Rapid, accurate publication and dissemination of clinical trial results: benefits and challengesFaiez Zannad, Filippo Crea, John Keaney, et al.Nature Communications|February 25, 2015
Observation of long-lived interlayer excitons in monolayer MoSe2-WSe2 heterostructuresPasqual Rivera, John R Schaibley, Aaron M Jones, et al.Circulation. Cardiovascular Quality and Outcomes|February 21, 2025
Variations in the Medical Device Authorization and Reimbursement Landscape: A Case Study of 2 Cardiovascular Devices Across 4 CountriesMarta M Williams, Nathan R Smith, Carin A Uyl-de Groot, et al.The Oncologist|March 9, 2021
A Challenging Task: Identifying Patients with Cancer of Unknown Primary (CUP) According to ESMO Guidelines: The CUPISCO Trial ExperienceChantal Pauli, Tilmann Bochtler, Linda Mileshkin, et al.The American Journal of Dermatopathology|January 4, 2017
Next-Generation Sequencing Reveals Pathway Activations and New Routes to Targeted Therapies in Cutaneous Metastatic MelanomaJ Andrew Carlson, Jose Candido Caldeira Xavier, Ashley Tarasen, et al.JCO Precision Oncology|July 6, 2023
Tumor Mutational Burden in Real-World Patients With Pancreatic Cancer: Genomic Alterations and Predictive Value for Immune Checkpoint Inhibitor EffectivenessJulia C F Quintanilha, Michael H Storandt, Ryon P Graf, et al.Pageof 289